Accurate Clinical Study of Medication in Patients With Depression Via Pharmacogenomics (PGx) and Therapeutic Drug Monitoring (TDM) of Venlafaxine

NCT04207385 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Depression

Interventions

DIAGNOSTIC_TEST: pharmacogenomics
DIAGNOSTIC_TEST: pharmacogenomics & therapeutic drug monitoring
DRUG: Venlafaxine

Sponsor

Xijing Hospital